Effect of particle size on the dissolution behaviors of poorly water-soluble drugs

This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystall...

Full description

Saved in:
Bibliographic Details
Published inArchives of pharmacal research Vol. 35; no. 7; pp. 1187 - 1195
Main Authors Chu, Kyung Rok, Lee, Eunhee, Jeong, Seong Hoon, Park, Eun-Seok
Format Journal Article
LanguageEnglish
Published Heidelberg Pharmaceutical Society of Korea 01.07.2012
대한약학회
Subjects
Online AccessGet full text
ISSN0253-6269
1976-3786
1976-3786
DOI10.1007/s12272-012-0709-3

Cover

Abstract This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles.
AbstractList This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 µm, 45˜¼150 µm, 150˜¼250 µm, and 250˜¼600 µm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles.
This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles.
This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles.This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45∼150 μm, 150∼250 μm, and 250∼600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles.
This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and mathematical analysis. As model drugs, hydrochlorothiazide, aceclofenac, ibuprofen and a discovery candidate were selected. The materials were crystallized using an evaporation method and milled without transformation behavior of crystal forms. The particles were sieved and divided into four size groups (< 45 μm, 45~150 μm, 150~250 μm, and 250~600 μm). The specific surface area with regard to the particle size was measured using a BET surface area measurement. The specific surface area increased with decreasing particle size of the drug, resulting in an increase in dissolution rate. During the initial period of the dissolution study, significant differences in dissolution rate were observed according to the particle size and specific surface areas. On the other hand, in the later stages, the surface-specific dissolution rate was almost consistent regardless of the particle size. These observations were evaluated mathematically and the results suggested that the dissolution rate of poorly soluble drugs is strongly related to the particle size distribution. Moreover, physicochemical analysis helped explain the effect of particle size on the dissolution profiles. KCI Citation Count: 56
Author Chu, Kyung Rok
Jeong, Seong Hoon
Lee, Eunhee
Park, Eun-Seok
Author_xml – sequence: 1
  givenname: Kyung Rok
  surname: Chu
  fullname: Chu, Kyung Rok
  organization: College of Pharmacy, Pusan National University
– sequence: 2
  givenname: Eunhee
  surname: Lee
  fullname: Lee, Eunhee
  organization: College of Pharmacy, Korea University
– sequence: 3
  givenname: Seong Hoon
  surname: Jeong
  fullname: Jeong, Seong Hoon
  email: shjeong@dongguk.edu
  organization: College of Pharmacy, Dongguk University-Seoul
– sequence: 4
  givenname: Eun-Seok
  surname: Park
  fullname: Park, Eun-Seok
  organization: School of Pharmacy, Sungkyunkwan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22864741$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001682636$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNqFkU1P3DAQhq2Kqiy0P6CXKsdyCPVX7OSI0PIhISEherYce7wYsvHWdqjor8chlEMP9GCNLD3veMbPAdobwwgIfSX4mGAsfyRCqaQ1JuVI3NXsA1qRToqayVbsoRWmDasFFd0-OkjpHmMmmqb5hPYpbQWXnKzQzdo5MLkKrtrpmL0ZoEr-D1RhrPIdVNanFIYp-3Lv4U4_-hDTCx1CHJ6q3zpDrGekL0kbp036jD46PST48loP0c-z9e3pRX11fX55enJVGy5lrntnTJkPJBe4A8sBekwpJbSVjcWalN0wc7q13HWNkLZrtLWcOUEktw5TdoiOlr5jdOrBeBW0f6mboB6iOrm5vVSEMElZU9jvC7uL4dcEKautTwaGQY8QpqSIZIWiLSf_RzGjZWLasYJ-e0WnfgtW7aLf6vik_n5vAcgCmBhSiuDeEILVrFAtClVRqGaFam4q_8kYn_UsIEfth3eTdEmm8sq4gajuwxTH4uCd0DNKBq20
CitedBy_id crossref_primary_10_1107_S2053229621012171
crossref_primary_10_1016_j_powtec_2016_05_065
crossref_primary_10_1002_anie_201307653
crossref_primary_10_3390_pharmaceutics14102173
crossref_primary_10_1080_17436753_2019_1706825
crossref_primary_10_3390_pharmaceutics14071504
crossref_primary_10_1186_s43094_021_00271_x
crossref_primary_10_3390_cryst12111565
crossref_primary_10_22159_ijap_2022v14i6_45975
crossref_primary_10_28979_jarnas_1448999
crossref_primary_10_1016_j_ijpharm_2024_124863
crossref_primary_10_1016_j_ejps_2014_11_012
crossref_primary_10_1088_1757_899X_736_6_062008
crossref_primary_10_1208_s12249_020_01701_4
crossref_primary_10_1007_s12247_020_09526_1
crossref_primary_10_1016_j_ejpb_2024_114480
crossref_primary_10_1016_j_trac_2014_01_008
crossref_primary_10_1089_jamp_2024_0036
crossref_primary_10_1039_D2EM00163B
crossref_primary_10_1007_s13346_017_0362_y
crossref_primary_10_1016_j_powtec_2022_117329
crossref_primary_10_1111_bcp_14977
crossref_primary_10_1155_2014_929248
crossref_primary_10_1208_s12249_013_9948_y
crossref_primary_10_1021_acs_cgd_0c00469
crossref_primary_10_33320_maced_pharm_bull_2022_68_03_125
crossref_primary_10_1021_acsomega_1c06708
crossref_primary_10_1680_jbibn_21_00065
crossref_primary_10_1007_s12247_020_09530_5
crossref_primary_10_1039_C8RA02106F
crossref_primary_10_1016_j_ijpharm_2023_123681
crossref_primary_10_1039_D0CP04498A
crossref_primary_10_3109_03639045_2013_858739
crossref_primary_10_1016_j_ijpharm_2020_119809
crossref_primary_10_1016_j_jddst_2025_106726
crossref_primary_10_1177_15593258221097594
crossref_primary_10_1016_j_colcom_2021_100536
crossref_primary_10_1016_j_ejpb_2019_01_010
crossref_primary_10_1007_s40005_020_00486_9
crossref_primary_10_1021_acs_molpharmaceut_8b00505
crossref_primary_10_1515_gps_2022_8107
crossref_primary_10_1016_j_ijpharm_2022_122502
crossref_primary_10_1016_j_apt_2021_05_040
crossref_primary_10_1021_acs_iecr_3c00811
crossref_primary_10_1111_jfpe_13729
crossref_primary_10_3390_pharmaceutics15122650
crossref_primary_10_3109_03639045_2015_1135936
crossref_primary_10_1016_j_cherd_2024_05_034
crossref_primary_10_52711_0974_360X_2023_00436
crossref_primary_10_1016_j_jcrysgro_2021_126263
crossref_primary_10_3390_polym13234072
crossref_primary_10_7317_pk_2015_39_1_6
crossref_primary_10_1002_ange_201307653
crossref_primary_10_1080_03639045_2024_2321388
crossref_primary_10_1016_j_jconrel_2022_05_006
crossref_primary_10_3390_pharmaceutics15102446
crossref_primary_10_1208_s12249_020_01811_z
crossref_primary_10_34172_PS_2019_52
crossref_primary_10_1002_ps_5573
crossref_primary_10_1007_s11095_024_03696_0
crossref_primary_10_1039_C5RA08318D
crossref_primary_10_1039_c3ce40938d
crossref_primary_10_1016_j_colsurfb_2020_110946
crossref_primary_10_1016_j_jiec_2021_05_032
crossref_primary_10_1002_jctb_7497
crossref_primary_10_1007_s12272_013_0180_9
crossref_primary_10_3390_pharmaceutics14051107
crossref_primary_10_1208_s12249_021_01962_7
crossref_primary_10_1007_s12247_018_9319_z
crossref_primary_10_1016_j_xphs_2019_03_013
crossref_primary_10_1021_acs_cgd_9b00200
crossref_primary_10_1016_j_ejpb_2021_12_004
crossref_primary_10_1016_j_ijpharm_2024_124010
crossref_primary_10_3390_pharmaceutics11040173
crossref_primary_10_3390_cryst12040550
crossref_primary_10_1016_j_ijpharm_2023_123580
crossref_primary_10_1080_10837450_2021_1872087
crossref_primary_10_1080_10837450_2023_2231074
Cites_doi 10.1002/jps.2600520310
10.1021/ja02086a003
10.1016/S0939-6411(00)00091-6
10.1016/0378-5173(95)00033-F
10.1016/0039-9140(94)00243-L
10.1016/S0378-5173(03)00005-X
10.1016/S0169-409X(97)00507-3
10.1016/0378-5173(95)04102-8
10.1002/jps.10480
10.1007/s10337-011-2111-6
10.1021/ie50260a018
10.1007/s12272-011-0511-7
10.1016/0378-5173(88)90235-9
10.1016/0378-5173(95)04312-8
10.1515/zpch-1904-4705
10.1358/mf.1998.20.3.485666
10.1515/zpch-1904-4704
ContentType Journal Article
Copyright The Pharmaceutical Society of Korea and Springer Netherlands 2012
Copyright_xml – notice: The Pharmaceutical Society of Korea and Springer Netherlands 2012
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
ACYCR
DOI 10.1007/s12272-012-0709-3
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
Korean Citation Index
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA

MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1976-3786
EndPage 1195
ExternalDocumentID oai_kci_go_kr_ARTI_1137235
22864741
10_1007_s12272_012_0709_3
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-53
-56
-5G
-BR
-EM
-Y2
-~C
.86
.UV
.VR
06C
06D
0R~
0VY
1N0
2.D
203
23N
29~
2J2
2JN
2JY
2KG
2KM
2LR
2VQ
2WC
2~H
30V
3SX
4.4
406
408
40D
40E
53G
5GY
5VS
67N
67Z
6J9
6NX
8TC
8UJ
95-
95.
95~
96X
9ZL
AAAVM
AABHQ
AACDK
AAHBH
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABECU
ABFTV
ABHQN
ABJNI
ABJOX
ABKCH
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFO
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACREN
ACSNA
ACUDM
ACZOJ
ADHHG
ADHIR
ADINQ
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEBTG
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFGCZ
AFLOW
AFQWF
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
ASPBG
AVWKF
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BGNMA
C1A
CAG
COF
CS3
CSCUP
DDRTE
DNIVK
DPUIP
EBLON
EBS
EIOEI
EJD
EMOBN
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GRRUI
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IKXTQ
IWAJR
IXC
IXD
I~X
I~Z
J-C
J0Z
JBSCW
JZLTJ
KOV
KPH
KVFHK
LLZTM
M4Y
MA-
MZR
N2Q
N9A
NDZJH
NF0
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OVD
P19
P2P
PF0
PT4
PT5
QOK
QOR
QOS
R89
R9I
RHV
RNI
RNS
ROL
RPX
RSV
RZK
S16
S1Z
S26
S27
S28
S3A
S3B
SAP
SBL
SCLPG
SDE
SDH
SHX
SISQX
SJN
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TUC
U2A
U9L
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W48
WK6
WK8
YLTOR
Z45
Z7U
Z7V
Z7W
Z83
Z87
Z8O
Z8P
Z8Q
Z91
ZMTXR
ZOVNA
ZZE
~A9
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
AABYN
AAFGU
AAKSU
AAPBV
AAYFA
ABFGW
ABKAS
ACBMV
ACBRV
ACBYP
ACIGE
ACIPQ
ACTTH
ACVWB
ACWMK
ACYCR
ADMDM
ADOXG
AEEQQ
AEFTE
AESTI
AEVTX
AFAFS
AFNRJ
AGGBP
AGKHE
AIMYW
AJDOV
AKQUC
UNUBA
Z7X
ID FETCH-LOGICAL-c477t-bfcc253e74609ed4eeb022212875d0a112203fa8d4f9567d95add43f6174df023
IEDL.DBID AGYKE
ISSN 0253-6269
1976-3786
IngestDate Tue Nov 21 21:44:09 EST 2023
Fri Sep 05 11:11:52 EDT 2025
Mon Jul 21 10:58:02 EDT 2025
Mon Jul 21 05:56:03 EDT 2025
Wed Oct 01 04:24:50 EDT 2025
Thu Apr 24 23:08:51 EDT 2025
Fri Feb 21 02:37:01 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Specific surface area
Particle size
Hixson-Crowell plot
Poorly water soluble drugs
Dissolution
Mean dissolution time
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-bfcc253e74609ed4eeb022212875d0a112203fa8d4f9567d95add43f6174df023
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000010.2012.35.7.007
PMID 22864741
PQID 1032609293
PQPubID 23479
PageCount 9
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_1137235
proquest_miscellaneous_1733532841
proquest_miscellaneous_1032609293
pubmed_primary_22864741
crossref_primary_10_1007_s12272_012_0709_3
crossref_citationtrail_10_1007_s12272_012_0709_3
springer_journals_10_1007_s12272_012_0709_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20120700
2012-7-00
2012-Jul
20120701
2012-07
PublicationDateYYYYMMDD 2012-07-01
PublicationDate_xml – month: 7
  year: 2012
  text: 20120700
PublicationDecade 2010
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: Korea (South)
PublicationTitle Archives of pharmacal research
PublicationTitleAbbrev Arch. Pharm. Res
PublicationTitleAlternate Arch Pharm Res
PublicationYear 2012
Publisher Pharmaceutical Society of Korea
대한약학회
Publisher_xml – name: Pharmaceutical Society of Korea
– name: 대한약학회
References Anderberg (CR1) 1992; 91
Brunner (CR4) 1904; 47
Brockmeier (CR3) 1986; 32
Noyes, Whitney (CR17) 1897; 19
Rasenack, Hartenhauer, Müller (CR20) 2003; 254
Coudoré, Harvard, Lefeuvre, Billaud, Beaune, Bobrie, Azizi, Prognon, Laurent (CR9) 2011; 74
Löbenberg, Amidon (CR13) 2000; 50
Hixson, Crowell (CR11) 1931; 23
Bisrat, Nyström (CR2) 1988; 47
CR18
Nernst (CR15) 1904; 47
Simões, Sousa, Figueiredo (CR21) 1996; 127
Kim, Sohn (CR12) 2011; 34
Mosharraf, Nyström (CR14) 1995; 122
Posac, Vázquez, Tascón, Acuña, de la Fuente, Velasco, Sánchez-Batanero (CR19) 1995; 42
Cao, Mullarney, Hancock, Bates, Morris (CR6) 2003; 92
Cospite, Dominici (CR8) 1989; 8
Chaumeil (CR7) 1998; 20
Fini, Fazio, Feroci (CR10) 1995; 126
Niebergall, Milsovich, Goyan (CR16) 1963; 52
Buckton (CR5) 1997; 26
A. W. Hixson (709_CR11) 1931; 23
R. Löbenberg (709_CR13) 2000; 50
D. Brockmeier (709_CR3) 1986; 32
A. Fini (709_CR10) 1995; 126
F. Coudoré (709_CR9) 2011; 74
E. K. Anderberg (709_CR1) 1992; 91
P. J. Niebergall (709_CR16) 1963; 52
G. Buckton (709_CR5) 1997; 26
J. C. Chaumeil (709_CR7) 1998; 20
M. Cospite (709_CR8) 1989; 8
N. Rasenack (709_CR20) 2003; 254
S. Simões (709_CR21) 1996; 127
B. Y. Kim (709_CR12) 2011; 34
M. Bisrat (709_CR2) 1988; 47
E. Brunner (709_CR4) 1904; 47
W. Cao (709_CR6) 2003; 92
M. Mosharraf (709_CR14) 1995; 122
A. Noyes (709_CR17) 1897; 19
W. Nernst (709_CR15) 1904; 47
J. R. Posac (709_CR19) 1995; 42
709_CR18
References_xml – volume: 52
  start-page: 236
  year: 1963
  end-page: 241
  ident: CR16
  article-title: Dissolution rate studies: II. Dissolution of particles under conditions of rapid agitation
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600520310
– ident: CR18
– volume: 19
  start-page: 930
  year: 1897
  end-page: 934
  ident: CR17
  article-title: The rate of solution of solid substances in their own solutions
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja02086a003
– volume: 50
  start-page: 3
  year: 2000
  end-page: 12
  ident: CR13
  article-title: Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/S0939-6411(00)00091-6
– volume: 122
  start-page: 35
  year: 1995
  end-page: 47
  ident: CR14
  article-title: The effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugs
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)00033-F
– volume: 42
  start-page: 293
  year: 1995
  end-page: 304
  ident: CR19
  article-title: Determination of aceclofenac using adsorptive stripping voltammetric techniques on conventional and surfactant chemically modified carbon paste electrodes
  publication-title: Talanta
  doi: 10.1016/0039-9140(94)00243-L
– volume: 91
  start-page: 8
  year: 1992
  ident: CR1
  article-title: Studies on the dissolution of fine particulate practically insoluble drugs and on the effect of surface active enhancers on gastrointestinal absorption of hydrophilic drugs
  publication-title: Acta Univ. Ups.
– volume: 254
  start-page: 137
  year: 2003
  end-page: 145
  ident: CR20
  article-title: Microcrystals for dissolution rate enhancement of poorly watersoluble drugs
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(03)00005-X
– volume: 26
  start-page: 17
  year: 1997
  end-page: 27
  ident: CR5
  article-title: Characterization of small changes in the physical properties of powders of significance for dry powder inhaler formulations
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/S0169-409X(97)00507-3
– volume: 126
  start-page: 95
  year: 1995
  end-page: 102
  ident: CR10
  article-title: Solubility and solubilization properties of non-steroidal anti-inflammatory drugs
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)04102-8
– volume: 20
  start-page: 211
  year: 1998
  end-page: 215
  ident: CR7
  article-title: Micronization: A method of improving the bioavailability of poorly soluble drugs
  publication-title: Methods Find. Exp. Clin. Pharmacol.
– volume: 92
  start-page: 2345
  year: 2003
  end-page: 2353
  ident: CR6
  article-title: Modeling of transmitted X-ray intensity variation with sample thickness and solid fraction in glycine compacts
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.10480
– volume: 47
  start-page: 52
  year: 1904
  end-page: 55
  ident: CR15
  article-title: Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen
  publication-title: Z. Phys. Chem.
– volume: 8
  start-page: 61
  year: 1989
  end-page: 65
  ident: CR8
  article-title: Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form
  publication-title: Int. Angiol.
– volume: 32
  start-page: 164
  year: 1986
  end-page: 174
  ident: CR3
  article-title: / correlation of dissolution using moments of dissolution and transit times
  publication-title: Acta Pharm. Technol.
– volume: 74
  start-page: 559
  year: 2011
  end-page: 565
  ident: CR9
  article-title: HPLC-DAD Analysis of Hydrochlorothiazide and Irbesartan in Hypertensive Patients on Fixed-Dose Combination Therapy
  publication-title: Chromatographia
  doi: 10.1007/s10337-011-2111-6
– volume: 23
  start-page: 923
  year: 1931
  end-page: 931
  ident: CR11
  article-title: Dependence of reaction velocity upon surface and agitation. I Theoretical consideration
  publication-title: Ind. Eng. Chem.
  doi: 10.1021/ie50260a018
– volume: 47
  start-page: 56
  year: 1904
  end-page: 102
  ident: CR4
  article-title: Theorie der Reaktionsgeschwindigkeit in heterogenen systemen
  publication-title: Z. Phys. Chem. (N F)
– volume: 34
  start-page: 775
  year: 2011
  end-page: 779
  ident: CR12
  article-title: Solid state of CG-400549, a novel FabI inhibitor: Characterization, dissolution, transformation
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-011-0511-7
– volume: 47
  start-page: 223
  year: 1988
  end-page: 231
  ident: CR2
  article-title: Physicochemical aspects of drug release: VIII. The relation between particle size and surface specific dissolution rate in agitated suspensions
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(88)90235-9
– volume: 127
  start-page: 283
  year: 1996
  end-page: 291
  ident: CR21
  article-title: Dissolution rate studies of pharmaceutical multisized powders — a practical approach using the Coulter method
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)04312-8
– volume: 91
  start-page: 8
  year: 1992
  ident: 709_CR1
  publication-title: Acta Univ. Ups.
– volume: 47
  start-page: 56
  year: 1904
  ident: 709_CR4
  publication-title: Z. Phys. Chem. (N F)
  doi: 10.1515/zpch-1904-4705
– volume: 23
  start-page: 923
  year: 1931
  ident: 709_CR11
  publication-title: Ind. Eng. Chem.
  doi: 10.1021/ie50260a018
– ident: 709_CR18
– volume: 52
  start-page: 236
  year: 1963
  ident: 709_CR16
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600520310
– volume: 19
  start-page: 930
  year: 1897
  ident: 709_CR17
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja02086a003
– volume: 122
  start-page: 35
  year: 1995
  ident: 709_CR14
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)00033-F
– volume: 127
  start-page: 283
  year: 1996
  ident: 709_CR21
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)04312-8
– volume: 26
  start-page: 17
  year: 1997
  ident: 709_CR5
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/S0169-409X(97)00507-3
– volume: 74
  start-page: 559
  year: 2011
  ident: 709_CR9
  publication-title: Chromatographia
  doi: 10.1007/s10337-011-2111-6
– volume: 42
  start-page: 293
  year: 1995
  ident: 709_CR19
  publication-title: Talanta
  doi: 10.1016/0039-9140(94)00243-L
– volume: 32
  start-page: 164
  year: 1986
  ident: 709_CR3
  publication-title: Acta Pharm. Technol.
– volume: 34
  start-page: 775
  year: 2011
  ident: 709_CR12
  publication-title: Arch. Pharm. Res.
  doi: 10.1007/s12272-011-0511-7
– volume: 50
  start-page: 3
  year: 2000
  ident: 709_CR13
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/S0939-6411(00)00091-6
– volume: 92
  start-page: 2345
  year: 2003
  ident: 709_CR6
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.10480
– volume: 8
  start-page: 61
  year: 1989
  ident: 709_CR8
  publication-title: Int. Angiol.
– volume: 126
  start-page: 95
  year: 1995
  ident: 709_CR10
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)04102-8
– volume: 47
  start-page: 223
  year: 1988
  ident: 709_CR2
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(88)90235-9
– volume: 254
  start-page: 137
  year: 2003
  ident: 709_CR20
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(03)00005-X
– volume: 20
  start-page: 211
  year: 1998
  ident: 709_CR7
  publication-title: Methods Find. Exp. Clin. Pharmacol.
  doi: 10.1358/mf.1998.20.3.485666
– volume: 47
  start-page: 52
  year: 1904
  ident: 709_CR15
  publication-title: Z. Phys. Chem.
  doi: 10.1515/zpch-1904-4704
SSID ssj0036555
Score 2.2913618
Snippet This study examined the effects of the particle size of various poorly water-soluble drugs on their dissolution behavior through physicochemical and...
SourceID nrf
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1187
SubjectTerms Chemistry, Pharmaceutical
Crystallization
Diclofenac - analogs & derivatives
Diclofenac - chemistry
evaporation
hydrochlorothiazide
Hydrochlorothiazide - chemistry
ibuprofen
Ibuprofen - chemistry
Kinetics
Medicine
Models, Chemical
Particle Size
particle size distribution
Pharmacology/Toxicology
Pharmacy
Solubility
Solvents - chemistry
surface area
Surface Properties
Technology, Pharmaceutical - methods
Water - chemistry
약학
Title Effect of particle size on the dissolution behaviors of poorly water-soluble drugs
URI https://link.springer.com/article/10.1007/s12272-012-0709-3
https://www.ncbi.nlm.nih.gov/pubmed/22864741
https://www.proquest.com/docview/1032609293
https://www.proquest.com/docview/1733532841
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001682636
Volume 35
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Archives of Pharmacal Research, 2012, 35(7), , pp.1187-1195
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: AFBBN
  dateStart: 19970201
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1976-3786
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0036555
  issn: 0253-6269
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fa9swED6aFMZetrbbuuxH0cbow1YVR5Kt-jGUdt1GRxkJdE_C1o9SUuxiJ4z0r98plhq2dYU--cFnI5-_033HSZ8APnCeZl7YjCYs11TolNHcpRnF4LDIToZGDP1G4dPv2clEfD1Pz8M-7jaudo8tyeVMvdrsxpj0ywj8aknfsO_Beurrkz6sjz7__HYUJ2CepcvDTjGbc4p8PY_NzLte8kc66lWNu4tp_tMlXSaf46cwjsPu1pxM9-ezcl_f_KXo-MDv2oAngYySUYeeTViz1RY8Og3t9i3YPeuErRd7ZLzap9XukV1ytpK8XjyDH50IMqkduQ5YJO3ljSV1RZBhEt_1DxgnURigXVrXdXO1IL-Q8TbUm5T4pGnmF-1zmBwfjQ9PaDitgWoh5YyWTmv0uJUiS3JrhLWlLyYx_8nUJAXyOpZwVxwY4bAmkyZPcWoV3CGFEsYhdXgB_aqu7Esg1mRaCMcMskOvZ19gKBuO-VbYokhMNoAk_jSlg5S5P1HjSq1EmL1TFTpVeacqPoCPt49cdzoe9xm_RySoqb5UXn3bXy9qNW0U1hhfsGbikvF0AO8iUBSGpO-zFJWt563yGoXoAyRS99hIjBKO3GA4gO0OZbfjYuwgE9Lf-RQRo8LM0v5_0K8eZP0aHrMOcoi8N9CfNXP7FunVrNwJ4bQDvQkb_QZ3NBfT
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fT9swED6NIm17YRv71Q02b5p4GBilthM3jwjByqAITUViT1biHwgVJShphcpfv3PjUI0xJJ7ykEvkXL7zfdadPwN84zxOvLAZjViqqdAxo6mLE4rBYZGd9Izo-Y3Cw-NkcCp-nsVnYR933Xa7tyXJ-Uy92OzGmPRtBL5b0hfsl2BZ9Pp90YHlnR-_D_faCZgn8fywU8zmnCJfT9ti5n0v-SsdLRWVu49p_lMlnSef_Rcwaofd9JyMt6eTfFvf3FF0fOR3vYSVQEbJToOeV_DEFqvwdBjK7auwcdIIW8-2yGixT6veIhvkZCF5PXsNvxoRZFI6chWwSOqLG0vKgiDDJL7qHzBOWmGAem5dltXljFwj462oN8nxSVNNz-s3cLq_N9od0HBaA9VCygnNndbocStFEqXWCGtzv5jE_CdjE2XI61jEXdY3wuGaTJo0xqlVcIcUShiH1OEtdIqysO-BWJNoIRwzyA69nn2GoWw45lthsywySRei9qcpHaTM_Ykal2ohwuydqtCpyjtV8S58v33kqtHxeMj4KyJBjfWF8urb_npeqnGlcI1xgGsmLhmPu_ClBYrCkPR1lqyw5bRWXqMQfYBE6gEbiVHCkRv0uvCuQdntuBjrJ0L6O5stYlSYWer_D_rDo6w_w7PBaHikjg6ODz_Cc9bAD1G4Bp1JNbXrSLUm-acQWn8ANc0Z2w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dS-QwEB90D8QX8fTUPe8jyuHDabCbpI19lDsXP05ZDhd8C90mEXFpl3aXY_3rndm2Locf4FMfOiklM5P5DZP5DcAPKcOIiM14IOKUqzQUPPZhxNE5HKKTjlUdahS-vIpO--r8Jryp55yWzW33piRZ9TQQS1M2PhxZfzhvfBNC05UCujlJxftF-KAwVFP21RfHzVEso3A29hTjuuSI3OOmrPnSJ_4LTItZ4V_CnM_qpbMw1F2FlRo_suNK4R9hwWVrsHRZV8jXYK9XcVFPD9j1vLWqPGB7rDdnqZ6uw9-Kt5jlno1q82Hl3YNjecYQFDIq1NdmyZpe_nImnefFcMr-IUgtOIkMcKUtJrflJ-h3T65_nfJ6wAJPldZjPvBpilvjtIqC2Fnl3IDyPwxZOrRBglBMBNInR1Z5TKO0jUM8DZX0iHqU9RjtN6CV5ZnbAuZslCrlhUVARxT0CXqflRgilUuSwEZtCJrdNWnNPk5DMIZmzptMCjGoEEMKMbINP5-WjCrqjbeEd1Fl5j69M0SYTc_b3NwXBtOCM0xzpBYybMNOo1GDXkSlkSRz-aQ0RCuIe4DY5w0ZjYYtMZx32rBZmcPTfwlxFClNb_Yb-zD1YVC-_tOf3yX9HZZ6v7vmz9nVxTYsi8py0YC_QGtcTNxXBEfjwbeZAzwCny4BXA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+particle+size+on+the+dissolution+behaviors+of+poorly+water-soluble+drugs&rft.jtitle=Archives+of+pharmacal+research&rft.au=Chu%2C+Kyung+Rok&rft.au=Lee%2C+Eunhee&rft.au=Jeong%2C+Seong+Hoon&rft.au=Park%2C+Eun-Seok&rft.date=2012-07-01&rft.pub=Pharmaceutical+Society+of+Korea&rft.issn=0253-6269&rft.eissn=1976-3786&rft.volume=35&rft.issue=7&rft.spage=1187&rft.epage=1195&rft_id=info:doi/10.1007%2Fs12272-012-0709-3&rft.externalDocID=10_1007_s12272_012_0709_3
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0253-6269&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0253-6269&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0253-6269&client=summon